PRESS RELEASE published on 02/16/2024 at 11:45, 9 months 5 days ago PlusPlus Capital reports unaudited Q4 2023 results – Invitation to earnings call on 20 February 2024 PlusPlus Capital reports unaudited Q4 2023 results and invites investors to earnings call on February 20, 2024. The pan-Baltic and Finnish receivables management group aims for market growth and social responsibility Earnings Call PlusPlus Capital Receivables Management Market Growth Unaudited Results
PRESS RELEASE published on 02/02/2024 at 13:30, 9 months 19 days ago PlusPlus Capital AS receives Court Approval for Reorganization PlusPlus Capital receives Court Approval for Reorganization in Estonia and prepares for reorganization proceedings in Luxembourg, aiming to inform investors of the reorganization plan and filing. PlusPlus is a technology-driven receivables management group focusing on diverse portfolios Reorganization PlusPlus Capital Estonia Luxembourg Receivables Management
PRESS RELEASE published on 11/03/2023 at 17:35, 1 year ago PlusPlus announces Results of Buyback offer for EUR 2022/2026 Bonds
PRESS RELEASE published on 10/11/2023 at 14:30, 1 year 1 month ago PlusPlus announces terms of Buyback offer for EUR 2022/2026 Bonds
PRESS RELEASE published on 09/27/2023 at 14:35, 1 year 1 month ago PlusPlus EUR 2022/2026 bondholders vote against termination of bonds and enforcement of guarantees
PRESS RELEASE published on 09/25/2023 at 11:00, 1 year 1 month ago PlusPlus progresses in raising funds and plans voluntary buyback program following adjourned bondholders’ meeting
PRESS RELEASE published on 09/19/2023 at 19:00, 1 year 2 months ago PlusPlus to hold adjourned bondholders meeting for EUR 2022/2026 bonds on 26 September 2023
PRESS RELEASE published on 08/30/2023 at 12:30, 1 year 2 months ago PlusPlus does not reach quorum in Bondholders’ Meeting
PRESS RELEASE published on 08/15/2023 at 16:40, 1 year 3 months ago PlusPlus Capital reports unaudited Q2 2023 results – Invitation to earnings call on 17 August 2023
PRESS RELEASE published on 07/31/2023 at 15:00, 1 year 3 months ago PlusPlus not to pay coupon of EUR 2022/2026 bonds on due date – Convening of bondholders' meeting to resolve a temporary standstill agreement
Published on 11/21/2024 at 22:05, 1 hour 49 minutes ago Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 2 hours 4 minutes ago Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 3 hours 39 minutes ago Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 3 hours 44 minutes ago For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform
Published on 11/21/2024 at 20:00, 3 hours 54 minutes ago Victory for New York Homeowners: Petroff Amshen LLP Blocks Lender’s Repeated Foreclosure Attempt
Published on 11/21/2024 at 19:01, 4 hours 52 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 5 hours 17 minutes ago Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 5 hours 55 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 6 hours 2 minutes ago LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 6 hours 2 minutes ago 2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.
Published on 11/21/2024 at 06:58, 16 hours 56 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 4 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 6 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 6 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 16 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo